查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946730

PD-L1 和 PIK3CA 檢測全球市場報告（2026 年）

PD-L1 And PIK3CA Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，PD-L1和PIK3CA檢測市場發展迅速，預計將從2025年的16.7億美元成長到2026年的19.3億美元，複合年成長率（CAGR）為15.5%。過去幾年的成長可歸因於PD-L1和PIK3CA檢測方法的開發、其在臨床試驗中的廣泛應用、癌症發生率的上升、分子診斷技術的進步以及人們對個人化治療認知的不斷提高。

預計未來幾年，PD-L1 和 PIK3CA 檢測市場將快速成長，到 2030 年市場規模將達到 34 億美元，複合年成長率 (CAGR) 為 15.2%。預測期內的成長要素包括人工智慧在生物標記檢測中的應用、液態生物檢體應用的擴展、精準腫瘤學的進步、診斷公司與製藥公司之間的合作以及下一代檢測方法的監管核准。預測期內的關鍵趨勢包括標靶癌症生物標記檢測、基於人工智慧的突變分析、液態生物檢體的應用、與藥物研發流程的整合以及高通量基因組篩檢。

癌症發生率的不斷上升預計將推動PD-L1和PIK3CA檢測市場的擴張。癌症的特徵是異常細胞不受控制地生長和擴散，由於生活方式相關的風險因素和人口老化等因素，癌症的發生率正在上升。這些因素導致診斷率上升，進而增加了對早期檢測和有效治療方案的需求。 PD-L1和PIK3CA檢測透過提供準確的診斷和指南標靶治療，從而有助於癌症管理，實現個人化治療。這將使治療方案能夠針對每位患者量身定做，並改善臨床療效。例如，根據美國癌症協會2024年9月發布的預測，全球男性癌症病例數預計將顯著增加，從2022年的1,030萬例增加至2029年的1,900萬例，增幅達84%。癌症病例的快速成長正在推動PD-L1和PIK3CA檢測市場的成長。

PD-L1 和 PIK3CA 檢測市場的主要企業正致力於技術創新，特別是伴隨診斷的整合，以改善治療標靶性並提高癌症治療的療效。伴隨診斷整合是指利用與標靶治療協同設計的先進檢測系統，根據患者的生物標記譜識別出最能從特定治療中獲益的患者群。例如，2024 年 10 月，總部位於瑞士的生物技術和製藥公司羅氏（F. Hoffmann-La Roche AG）推出了 Itobevi（inavolisib）聯合治療Palbociclib和 fulvestrant 的方案，用於治療內分泌抗藥性、PIK3CA 突變、HR 陽性、HER2 陰性患者的進行性或轉移性乳癌患者。 FDA 基於 III 期 INAVO120 試驗的結果核准了該治療方法，該試驗表明，與單獨使用Palbociclib和 fulvestrant 相比，該方案可使無惡化生存期延長兩倍以上。這是羅氏首個針對 HR 陽性疾病的標靶治療，其中包含用於識別合格患者的伴隨診斷，代表著精準醫療在治療選擇有限的患者群體中取得的重大進展。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球PD-L1和PIK3CA檢測市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 標靶癌症生物標記檢測
    • 基於人工智慧的突變分析
    • 液態生物檢體簡介
    • 與藥物研發部門合作
    • 高通量基因組篩檢

第5章 終端用戶產業市場分析

  • 醫院
  • 研究所
  • 製藥公司
  • 研究所
  • 診斷中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球PD-L1和PIK3CA檢測市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球PD-L1及PIK3CA檢測市場規模、比較及成長率分析
  • 全球PD-L1和PIK3CA檢測市場表現：規模和成長，2020-2025年
  • 全球PD-L1和PIK3CA檢測市場預測：規模和成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按測試類型
  • 免疫組織化學、次世代定序、聚合酵素鏈鎖反應
  • 依樣本類型
  • 組織樣本、液態生物檢體樣本
  • 透過使用
  • 癌症診斷、藥物開發、研究及其他應用
  • 最終用戶
  • 醫院、診所、研究機構、製藥公司
  • 按類型細分：免疫組織化學
  • 組織染色、蛋白質表現分析
  • 按類型細分：次世代定序
  • 全基因測序、標靶基因定序、EXOME定序、核糖核酸（RNA）定序
  • 按類型細分：聚合酵素鏈鎖反應
  • 定量聚合酵素鏈鎖反應，數位聚合酵素鏈鎖反應

第10章 區域與國家分析

  • 全球PD-L1及PIK3CA檢測市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球PD-L1和PIK3CA檢測市場：國家/地區、效能和預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • PD-L1 和 PIK3CA 檢測市場：競爭格局和市場佔有率，2024 年
  • PD-L1 和 PIK3CA 檢測市場：公司估值矩陣
  • PD-L1 和 PIK3CA 檢測市場：公司概況
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings（Labcorp）
    • Quest Diagnostics Incorporated

第37章：其他領先和創新企業

  • Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Myriad Genetics Inc., NeoGenomics Laboratories Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences, Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., ACCB Biotech Private Limited, EntroGen Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年PD-L1和PIK3CA檢測市場：提供新機會的國家
  • 2030 年 PD-L1 和 PIK3CA 檢測市場：充滿新機會的細分市場
  • 2030 年 PD-L1 和 PIK3CA 檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MPLPT01_G26Q1

PD-L1 and PIK3CA testing are molecular diagnostic methods used to identify specific biomarkers that support targeted cancer treatment decisions. PD-L1 testing measures the expression of the programmed death ligand 1 protein on tumor cells to evaluate the likelihood of response to immunotherapies. PIK3CA testing identifies mutations in the phosphatidylinositol 4,5 bisphosphate 3 kinase catalytic subunit alpha gene, which helps determine eligibility for therapies directed at the PI3K pathway.

The primary test types of PD-L1 and PIK3CA testing include immunohistochemistry, next generation sequencing, polymerase chain reaction, and others. Immunohistochemistry is a laboratory method that applies antibodies to detect specific proteins in tissue samples, making it possible to visualize their location and concentration under a microscope. The sample types used are tissue samples and liquid biopsy samples. The distribution channels include direct sales, distributors and resellers, and online sales platforms. The applications involve cancer diagnosis, drug development, research, and other uses, and they serve multiple end users such as hospitals and clinics, laboratories, and pharmaceutical companies.

Tariffs are impacting the pd-l1 and pik3ca testing market by increasing costs for imported sequencing kits, reagents, and diagnostic instruments. Hospitals, laboratories, and pharmaceutical companies in Asia-Pacific and Europe are most affected. Segments such as immunohistochemistry and next-generation sequencing kits face higher import costs. Positive impacts include promoting local manufacturing of reagents and kits, fostering innovation, and reducing dependency on international suppliers.

The pd-l1 and pik3ca testing market research report is one of a series of new reports from The Business Research Company that provides pd-l1 and pik3ca testing market statistics, including pd-l1 and pik3ca testing industry global market size, regional shares, competitors with a pd-l1 and pik3ca testing market share, detailed pd-l1 and pik3ca testing market segments, market trends and opportunities, and any further data you may need to thrive in the pd-l1 and pik3ca testing industry. This pd-l1 and pik3ca testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pd-l1 and pik3ca testing market size has grown rapidly in recent years. It will grow from $1.67 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to development of pd-l1 and pik3ca assays, adoption in clinical trials, growing cancer prevalence, advancements in molecular diagnostics, awareness of personalized therapy.

The pd-l1 and pik3ca testing market size is expected to see rapid growth in the next few years. It will grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to integration of ai in biomarker detection, growth of liquid biopsy applications, expansion in precision oncology, partnerships between diagnostics and pharma companies, regulatory approvals for next-gen assays. Major trends in the forecast period include targeted cancer biomarker testing, ai-based mutation analysis, liquid biopsy adoption, integration with drug development, high-throughput genomic screening.

The growing prevalence of cancer is expected to drive the expansion of the PD-L1 and PIK3CA testing market. Cancer, which is characterized by the uncontrolled growth and spread of abnormal cells, has become more common due to factors such as lifestyle-related risks and an aging population. These factors contribute to higher diagnosis rates and an increased demand for early detection and effective treatment solutions. PD-L1 and PIK3CA testing help manage cancer by providing accurate diagnoses and guiding targeted therapies, which allow treatments to be personalized to individual patients and improve clinical outcomes. For example, in September 2024, the American Cancer Society projected a significant increase in global cancer cases among men, estimating an 84% rise by 2029, from 10.3 million in 2022 to 19 million. This surge in cancer cases is driving the growth of the PD-L1 and PIK3CA testing market.

Key players in the PD-L1 and PIK3CA testing market are focusing on technological advancements, particularly the integration of companion diagnostics, to improve therapeutic targeting and enhance treatment efficacy in oncology. Companion diagnostic integration involves advanced testing systems designed alongside targeted medicines to identify patient groups most likely to benefit from specific treatments based on biomarker profiles. For instance, in October 2024, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology and pharmaceutical company, introduced Itovebi (inavolisib) in combination with palbociclib and fulvestrant for patients with endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative advanced or metastatic breast cancer. The FDA approved this regimen based on the Phase III INAVO120 study, which showed more than double the progression-free survival compared to palbociclib and fulvestrant alone. This marks Roche's first targeted therapy for HR-positive disease and incorporates a companion diagnostic to identify eligible patients, representing a major step forward in precision medicine for a patient population with limited treatment options.

In September 2025, Labcorp, a U.S.-based provider of comprehensive clinical laboratory services and drug development solutions, purchased select oncology and oncology-related clinical testing assets from BioReference Health for up to $225 million. Through this acquisition, Labcorp seeks to broaden its oncology diagnostics portfolio and enhance nationwide access to high-value cancer testing services by incorporating BioReference's specialized oncology capabilities and client accounts. BioReference Health is a U.S.-based provider of oncology-focused laboratory testing services, delivering advanced cancer diagnostics, clinical testing solutions, and regional clinical laboratory operations.

Major companies operating in the pd-l1 and pik3ca testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., NeoGenomics Laboratories Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences, Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., ACCB Biotech Private Limited, EntroGen Inc.

North America was the largest region in the PD-L1 and PIK3CA testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pd-l1 and pik3ca testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pd-l1 and pik3ca testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The PD-L1 and PIK3CA testing market includes revenues earned by entities through the biomarker testing, molecular diagnostics, genetic mutation detection, generation sequencing services, companion diagnostic testing, pathology interpretation, and clinical trial testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

PD-L1 And PIK3CA Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pd-l1 and pik3ca testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pd-l1 and pik3ca testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pd-l1 and pik3ca testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Immunohistochemistry; Next-Generation Sequencing; Polymerase Chain Reaction
  • 2) By Sample Type: Tissue Samples; Liquid Biopsy Samples
  • 3) By Applications: Cancer Diagnosis; Drug Development; Research; Other Applications
  • 4) By End User: Hospitals And Clinics; Laboratories; Pharmaceutical Companies
  • Subsegments:
  • 1) By Immunohistochemistry: Tissue Staining; Protein Expression Analysis
  • 2) By Next-Generation Sequencing: Whole Genome Sequencing; Targeted Gene Sequencing; Exome Sequencing; Ribonucleic Acid (RNA) Sequencing
  • 3) By Polymerase Chain Reaction: Quantitative Polymerase Chain Reaction; Digital Polymerase Chain Reaction
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Laboratory Corporation of America Holdings (Labcorp); Quest Diagnostics Incorporated; Eurofins Scientific SE; Agilent Technologies Inc.; Sonic Healthcare Limited; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Myriad Genetics Inc.; NeoGenomics Laboratories Inc.; BGI Genomics Co. Ltd.; Guardant Health Inc.; Caris Life Sciences; Foundation Medicine Inc.; Amoy Diagnostics Co. Ltd.; ACCB Biotech Private Limited; EntroGen Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pd-L1 And Pik3Ca Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pd-L1 And Pik3Ca Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pd-L1 And Pik3Ca Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pd-L1 And Pik3Ca Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Targeted Cancer Biomarker Testing
    • 4.2.2 Ai-Based Mutation Analysis
    • 4.2.3 Liquid Biopsy Adoption
    • 4.2.4 Integration With Drug Development
    • 4.2.5 High-Throughput Genomic Screening

5. Pd-L1 And Pik3Ca Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Laboratories
  • 5.3 Pharmaceutical Companies
  • 5.4 Research Institutes
  • 5.5 Diagnostic Centers

6. Pd-L1 And Pik3Ca Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pd-L1 And Pik3Ca Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pd-L1 And Pik3Ca Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pd-L1 And Pik3Ca Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pd-L1 And Pik3Ca Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pd-L1 And Pik3Ca Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pd-L1 And Pik3Ca Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pd-L1 And Pik3Ca Testing Market Segmentation

  • 9.1. Global Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunohistochemistry, Next-Generation Sequencing, Polymerase Chain Reaction
  • 9.2. Global Pd-L1 And Pik3Ca Testing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue Samples, Liquid Biopsy Samples
  • 9.3. Global Pd-L1 And Pik3Ca Testing Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer Diagnosis, Drug Development, Research, Other Applications
  • 9.4. Global Pd-L1 And Pik3Ca Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Laboratories, Pharmaceutical Companies
  • 9.5. Global Pd-L1 And Pik3Ca Testing Market, Sub-Segmentation Of Immunohistochemistry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue Staining, Protein Expression Analysis
  • 9.6. Global Pd-L1 And Pik3Ca Testing Market, Sub-Segmentation Of Next-Generation Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Whole Genome Sequencing, Targeted Gene Sequencing, Exome Sequencing, Ribonucleic Acid (RNA) Sequencing
  • 9.7. Global Pd-L1 And Pik3Ca Testing Market, Sub-Segmentation Of Polymerase Chain Reaction, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Quantitative Polymerase Chain Reaction, Digital Polymerase Chain Reaction

10. Pd-L1 And Pik3Ca Testing Market Regional And Country Analysis

  • 10.1. Global Pd-L1 And Pik3Ca Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pd-L1 And Pik3Ca Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pd-L1 And Pik3Ca Testing Market

  • 11.1. Asia-Pacific Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pd-L1 And Pik3Ca Testing Market

  • 12.1. China Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pd-L1 And Pik3Ca Testing Market

  • 13.1. India Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pd-L1 And Pik3Ca Testing Market

  • 14.1. Japan Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pd-L1 And Pik3Ca Testing Market

  • 15.1. Australia Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pd-L1 And Pik3Ca Testing Market

  • 16.1. Indonesia Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pd-L1 And Pik3Ca Testing Market

  • 17.1. South Korea Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pd-L1 And Pik3Ca Testing Market

  • 18.1. Taiwan Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pd-L1 And Pik3Ca Testing Market

  • 19.1. South East Asia Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pd-L1 And Pik3Ca Testing Market

  • 20.1. Western Europe Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pd-L1 And Pik3Ca Testing Market

  • 21.1. UK Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pd-L1 And Pik3Ca Testing Market

  • 22.1. Germany Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pd-L1 And Pik3Ca Testing Market

  • 23.1. France Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pd-L1 And Pik3Ca Testing Market

  • 24.1. Italy Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pd-L1 And Pik3Ca Testing Market

  • 25.1. Spain Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pd-L1 And Pik3Ca Testing Market

  • 26.1. Eastern Europe Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pd-L1 And Pik3Ca Testing Market

  • 27.1. Russia Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pd-L1 And Pik3Ca Testing Market

  • 28.1. North America Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pd-L1 And Pik3Ca Testing Market

  • 29.1. USA Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pd-L1 And Pik3Ca Testing Market

  • 30.1. Canada Pd-L1 And Pik3Ca Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pd-L1 And Pik3Ca Testing Market

  • 31.1. South America Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pd-L1 And Pik3Ca Testing Market

  • 32.1. Brazil Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pd-L1 And Pik3Ca Testing Market

  • 33.1. Middle East Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pd-L1 And Pik3Ca Testing Market

  • 34.1. Africa Pd-L1 And Pik3Ca Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pd-L1 And Pik3Ca Testing Market, Segmentation By Test Type, Segmentation By Sample Type, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pd-L1 And Pik3Ca Testing Market Regulatory and Investment Landscape

36. Pd-L1 And Pik3Ca Testing Market Competitive Landscape And Company Profiles

  • 36.1. Pd-L1 And Pik3Ca Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pd-L1 And Pik3Ca Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pd-L1 And Pik3Ca Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Laboratory Corporation of America Holdings (Labcorp) Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Pd-L1 And Pik3Ca Testing Market Other Major And Innovative Companies

  • Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., NeoGenomics Laboratories Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences, Foundation Medicine Inc., Amoy Diagnostics Co. Ltd., ACCB Biotech Private Limited, EntroGen Inc.

38. Global Pd-L1 And Pik3Ca Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pd-L1 And Pik3Ca Testing Market

40. Pd-L1 And Pik3Ca Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Pd-L1 And Pik3Ca Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Pd-L1 And Pik3Ca Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Pd-L1 And Pik3Ca Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer